Conditional Value-at-Risk: Structure and Complexity of Equilibria

M. Mavronicolas,B. Monien

DOI: https://doi.org/10.1007/978-3-319-66700-3_11

2017-09-12

Abstract:

What problem does this paper attempt to address?

Infinitely Many Heteroclinic Orbits of a Complex Lorenz System

Haijun Wang,Xianyi Li

DOI: https://doi.org/10.1142/S0218127417501103

2017-07-21

Abstract:The existence of heteroclinic orbits of a chaotic system is a difficult yet interesting mathematical problem. Nowadays, a rigorous analytical proof for the existence of a heteroclinic orbit can be carried out only for some special chaotic and hyperchaotic systems, and few results are known for the complex systems. In this paper, by revisiting a complex Lorenz system, it is found that this system possesses an infinite set of heteroclinic orbits to the origin and its circle equilibria. However, it is impossible for the corresponding real Lorenz system to have infinitely many heteroclinic orbits. The theoretical tools for proving the main results are Lyapunov functions and the definitions of α-limit set and ω-limit set. Numerical simulations show the effectiveness and correctness of the theoretical conclusions. The investigations not only enrich the related results for the complex Lorenz system, but also find the essential difference between the complex Lorenz system and its corresponding real version: the complex Lorenz system has infinitely many heteroclinic orbits whereas its corresponding real one does not.
Femtosecond laser-assisted lock-and-key shaped penetrating keratoplasty

S. Fung,A. Iovieno,V. Shanmuganathan,V. Chowdhury,V. Maurino

DOI: https://doi.org/10.1136/bjophthalmol-2011-301035

2011-12-12

British Journal of Ophthalmology

Abstract:The advent of the femtosecond laser in ophthalmology allows precise and customised corneal graft configurations at the graft-host junction. Recent studies have yielded a variety of wound shapes, all of which increase the surface area at the graft-host junction, resulting in better wound approximation, faster healing and earlier suture removal with comparable or reduced astigmatism.1–5 Among them, the mushroom and top hat configurations have been shown to be mechanically more stable than the traditional penetrating keratoplasty (PK) and other wound shapes when sutures were applied.5 This enhanced stability was attributed to the peripheral flange that acts as a valve and prevents wound leakage. In this study, we developed a novel ‘lock-and-key’ configuration for PK …
Creatinine-to-cystatin C Ratio As a Marker of Skeletal Muscle Mass for Predicting Postoperative Complications in Patients Undergoing Gastric Cancer Surgery.

Jiaqi Gao,Huiping Liang,Yun Qian,Junhai Pan,Wei Liu,Weilin Qi,Wei Zhou,Xiaolong Ge,Xianfa Wang

DOI: https://doi.org/10.21037/apm-20-2366

2021-01-01

Annals of Palliative Medicine

Abstract:BACKGROUND:Gastric cancer patients usually suffer from skeletal muscle depletion. The serum creatinine/cystatin C ratio (CCR) is a new, simple tool that could serve as a biomarker of skeletal muscle mass. This study explored the ability of the preoperative CCR to predict postoperative complications in patients with gastric cancer.METHODS:A total of 309 patients with gastric cancer who were undergoing surgery were enrolled in this study. Univariate analyses were conducted to determine the potential risk factors for postoperative complications, and multivariate analyses were used to determine the independent influencing factors of postoperative complications. A receiver operating characteristic curve was conducted to identify the optimal cutoff value of the CCR. Patients were divided into two groups according to the critical value to investigate the relationship between the CCR and postoperative complications.RESULTS:Postoperative complications occurred in 87 patients. Multivariate analysis suggested that age, red blood cell level, lymphocyte count, cystatin C, CCR, and N factor were independent risk or protective factors for postoperative complications (P<0.001). The optimal cutoff value of the preoperative CCR was 7.117. Compared with the high preoperative CCR group, patients with a low preoperative CCR were more likely to have both mild complications (P<0.001) and major complications (P<0.001).CONCLUSIONS:The preoperative CCR can effectively predict postoperative complications in gastric cancer patients after surgery.
Cardiovascular changes during transport of critically ill and postoperative patients

J. Insel,C. Weissman,M. Kemper,A. Hyman

DOI: https://doi.org/10.1097/00003246-198606000-00004

IF: 8.8

1986-06-01

Critical Care Medicine

Abstract:We examined cardiovascular changes in 37 patients transported to an ICU after major general or vascular surgery (n = 14), open heart surgery (n = 13), or carotid endarterectomy (n = 10). Cardiovascular variables were also measured in a control group of 11 patients transported from an ICU for diagnostic or therapeutic procedures. All patients were followed for 30 min before transport until approximately 30 min after they arrived at their destinations. During this period, systolic BP and heart rate significantly increased only in patients recovering from major general/vascular surgery or carotid endarterectomy. These changes were apparently related to acute emergence from inhalational anesthesia (isoflurane plus nitrous oxide), since the other surgical patients were anesthetized with narcotic anesthesia, and the control group did not receive any anesthesia.
Quantitative Computed Tomography Assessment of Pectoralis and Erector Spinae Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease Referred for Lung Volume Reduction

Amy H. Attaway,Nicole Welch,Ruchi Yadav,Annette Bellar,Umur Hatipoğlu,Yvonne Meli,Marielle P. K. J. Engelen,Joe Zein,Srinivasan Dasarathy

DOI: https://doi.org/10.1080/15412555.2021.1897560

2021-03-04

Abstract:Patients with advanced chronic obstructive pulmonary disease (COPD) develop skeletal muscle loss (sarcopenia) that is associated with adverse clinical outcomes including mortality. We evaluated if thoracic muscle area is associated with clinical outcomes in patients with severe COPD. We analyzed consecutive patients with severe COPD undergoing evaluation for lung volume reduction from 2015 to 2019 (n = 117) compared to current and former smoking controls undergoing lung cancer screening with normal lung function (n = 41). Quantitative assessments of pectoralis muscle (PM) and erector spinae muscle (ESM) cross sectional area (CSA) were related to clinical outcomes including composite endpoints. Our results showed a reduction in PM CSA but not ESM CSA was associated with the severity of GOLD stage of COPD. Current smokers demonstrated reduced PM CSA which was similar to that in COPD patients who were GOLD stages 3 and 4. PM CSA was associated positively with FEV1, FEV1% predicted, FVC, DLCO, and FEV1/FVC ratio, and was associated negatively with the degree of radiologic emphysema. ESM correlated positively with DLCO, RV/TLC (a marker of hyperinflation), and correlated negatively with radiologic severity of emphysema. Kaplan-Meier analysis showed that reductions in PM but not ESM CSA was associated with the composite end point of mortality, need for lung volume reduction, or lung transplant. In conclusion, in well-characterized patients with severe COPD referred for lung volume reduction, PM CSA correlated with severity of lung disease, mortality, and need for advanced therapies. In addition to predicting clinical outcomes, targeting sarcopenia is a potential therapeutic approach in patients with severe COPD.
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

Kohei Fujita,Hirotsugu Ohkubo,Akiko Nakano,Norihisa Takeda,Kensuke Fukumitsu,Satoshi Fukuda,Yoshihiro Kanemitsu,Takehiro Uemura,Tomoko Tajiri,Ken Maeno,Yutaka Ito,Tetsuya Oguri,Yoshiyuki Ozawa,Takayuki Murase,Akio Niimi

DOI: https://doi.org/10.1186/s12890-022-02000-3

2022-05-23

Abstract:Background: The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary fibrosis (IPF). This study aimed to confirm the utility of the serum Cr/CysC ratio in predicting sarcopenia and investigate its clinical relevance. Methods: This cross-sectional pilot study prospectively enrolled patients with stable IPF. IPF was diagnosed through multidisciplinary discussions according to the 2018 international guidelines, and sarcopenia was diagnosed according to the 2019 consensus report of the Asian Working Group for Sarcopenia. Patient-reported outcomes (PROs) were evaluated using the modified Medical Research Council (mMRC) dyspnea scale, chronic obstructive pulmonary disease assessment test (CAT), and King's Brief Interstitial Lung Disease (K-BILD) questionnaire. The associations between serum Cr/CysC ratio and the presence of sarcopenia and other clinical parameters, including PROs scores, were examined. Results: The study enrolled 49 Japanese patients with IPF with a mean age of 73.0 ± 7.7 years and a mean percentage of predicted forced vital capacity of 80.4 ± 15.5%. Sarcopenia was diagnosed in 18 patients (36.7%), and the serum Cr/CysC ratio was 0.86 [0.76-0.94] (median [interquartile range]). The receiver operating characteristic curve analyses for the detection of sarcopenia according to the serum Cr/CysC showed that the area under the curve, optimal cutoff value, specificity, and sensitivity were 0.85, 0.88, 0.65, and 0.94, respectively. Sarcopenia was identified in 13% of patients with a high serum Cr/CysC ratio (≥ 0.88) and 60% of patients with a low serum Cr/CysC ratio (< 0.88) (P < 0.001). Multiple linear regression analysis showed that the serum Cr/CysC ratio was an independent predictive marker of worse PROs evaluated using mMRC (P < 0.05), CAT (P < 0.05), and K-BILD (P < 0.05). Conclusions: This study showed that the serum Cr/CysC ratio may be a surrogate marker of sarcopenia in patients with IPF. Furthermore, it is important to pay attention to the serum Cr/CysC ratio because a lower serum Cr/CysC ratio is associated with worse PROs. Further studies are required to validate these observations to determine whether the Cr/CysC ratio can be used to detect sarcopenia in patients with IPF.
Letter: Ultrasound in diagnosis of empyema.

A. S. Mahal,A. B. Weisse,P. A. Bolanowski,L. Reichman

IF: 39.2

1975-07-01

Annals of Internal Medicine

Abstract:
The creatinine-to-cystatin C ratio (a surrogate marker of muscle mass) as a predictor of lung function decline in older adults: A nationwide longitudinal study in China

Ke Wang,Shuli Jia,Wanyu Zhao,Meiling Ge,Birong Dong

DOI: https://doi.org/10.1016/j.rmed.2023.107197

IF: 4.3

2023-05-01

Respiratory Medicine

Abstract:BackgroundLung function decline is associated with sarcopenia, known as loss of skeletal muscle mass. The serum creatinine to cystatin C ratio (CCR) has been proposed as a biomarker of muscle mass. The associations between CCR and lung function decline are unknown.MethodsThe study used two waves of data from China Health and Retirement Longitudinal Study (CHARLS) in 2011 and 2015. Serum creatinine and cystatin C were collected at baseline survey (2011). Lung function was assessed by peak expiratory flow (PEF) at 2011 and 2015. Linear regression models adjusted for potential confounders were conducted to analyze the cross-sectional association between CCR and PEF, and the longitudinal association between CCR and annual decline in PEF.ResultsTotally, 5812 participants aged over 50 years (50.8% women; mean age 63.3 ± 6.5 years) were enrolled in a cross-sectional analysis in 2011, and further 4164 individuals were followed up in 2015. Serum CCR was positively associated with PEF and the PEF% pred. Per 1 SD higher of CCR was associated with 41.55 L/min increases in PEF (p < 0.001) and 10.77 (%) increase in PEF% pred (p < 0.001). Longitudinal analyses indicated that higher CCR level at baseline was related to slower annual decline in PEF and PEF% pred. And this relationship was significant only in women and in never smokers.ConclusionsHigher CCR was associated with slower longitudinal PEF decline in women and never smokers. CCR may be a valuable marker to monitor and predict lung function decline in middle-aged and older adults.

cardiac & cardiovascular systems,respiratory system
Ageing, remembering, and executive function

D. Clarys,Aurélia Bugaiska,G. Tapia,and Alexia Baudouin

DOI: https://doi.org/10.1080/09658210802188301

2009-02-01

Memory

Abstract:This study was designed to investigate the relationship between executive functions and the age-related decline in episodic memory through the states-of-awareness approach. Following the presentation of a word list, a group of younger adults and a group of older adults undertook a recognition test in which they classified their responses according to the Remember-Know-Guess procedure (Gardiner & Richardson-Klavehn, 2000). In order to operationalise the executive function hypothesis, we investigated three specific executive functions (updating, shifting, and inhibition of a prepotent response) described in Miyake et al.'s (2000) theoretical model, and a complex executive task. The results revealed that fewer “R” responses were made during the recognition test by the older than the younger group, whereas there was no difference between the groups in the number of “K” responses. In addition, correlations indicated that remembering depended on executive function measures, whereas knowing did not. The hierarchical regression analyses showed that controlling for executive function, and particularly for the 2-back test, largely removed the age-related variance in remembering. These findings support the notion that executive dysfunction, and specifically updating decline, plays a central role in age-related memory loss.
Serum cystatin C and indices of lung function in elderly Chinese men with chronic obstructive pulmonary disease

Meng Zhang,Shu-Hong Fu,Hua Cui,Bing-Po Zhu,Lin Liu,De-Long Wang

DOI: https://doi.org/10.1007/s40520-013-0150-6

2013-10-08

Aging Clinical and Experimental Research

Abstract:ObjectiveThe aim of this cross-sectional case–control study was to determine the relationship between serum cystatin C (sCysC) levels and lung function in elderly male patients with chronic obstructive pulmonary disease (COPD).MethodsThis study included 251 Chinese men (age ≥ 65 years) who were divided into COPD (n = 129) and non-COPD (n = 122) groups. Participants underwent lung function and laboratory testing, including measurement of sCysC levels. Relationships between sCysC concentration and indices of lung function were assessed by multiple regression analysis.ResultsParticipants in the COPD group displayed higher sCysC concentrations (P = 0.041) and lower lung function (P < 0.001) compared to participants in the non-COPD group. Multiple linear regression analyses revealed that the reciprocal of the sCysC concentration (1/sCysC) was positively associated with the predicted forced expiratory volume in 1 s in all subjects (β = 0.156, P = 0.009). The findings indicate that high sCysC levels were directly associated with decreased lung function in elderly Chinese men with COPD.ConclusionsHigh sCysC concentration may be a potential indicator of impaired lung function, and its application may improve the diagnosis and assessment of COPD severity in elderly male patients.

geriatrics & gerontology,gerontology
Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis

Wen-He Zheng,Yi-Bing Zhu,Yan Yao,Hui-Bin Huang

DOI: https://doi.org/10.3389/fmed.2022.1058464

IF: 3.9

2023-01-09

Frontiers in Medicine

Abstract:Objective Sarcopenia is a syndrome of decreased muscle mass and deficits in muscle strength and physical function. We aimed to investigate the relationship between creatinine/cystatin C ratio (CCR) and sarcopenia and the prognostic value of CCR in hospitalized patients. Materials and methods We searched for relevant studies in PubMed, EMBASE, and the Cochrane Database up to August 25, 2022. Meta-analyses were performed to evaluate the relationship between CCR and skeletal muscle [computed tomography-assessed skeletal muscle (CTASM), muscle strength, and physical performance], prognosis and important clinical outcomes in hospitalized adults. The pooled correlation coefficient, the area under the receiver operating characteristic (ROC) curves, and hazard ratio (HR) together with their 95% confidence intervals (CIs) were calculated. We also conducted subgroup analyses to explore the sources of heterogeneity. Results A total of 38 studies with 20,362 patients were eligible. These studies were of moderate to high quality. Our results showed that CCR was significant correlations with all CTASM types (Fisher’s Z ranged from 0.35 to 0.5; P values ranged from < 0.01 to 0.01), handgrip strength (Fisher’s Z = 0.39; 95% CI, 0.32–0.45; P < 0.001) and gait speed (Fisher’s Z = 0.25; 95% CI, 0.21–0.30; P < 0.001). The ROC curves suggested that CCR had good diagnostic efficacy (0.689; 95% CI, 0.632–0.746; P < 0.01) for sarcopenia. CCR can reliably predict mortality in hospitalized patients, which was confirmed by regression analysis of CCR as both continuous (HR 0.78; 95% CI, 0.72–0.84; P < 0.01) and categorical variables (HR 2.05; 95% CI, 1.58–2.66; P < 0.0001). In addition, less evidence showed that higher CCR was independently associated with a shorter duration of mechanical ventilation, reduced length of stay in the intensive care unit and hospital, less nutritional risk, and decreased complications in hospitalized patients. Conclusion CCR could be a simple, economical, and effective screening tool for sarcopenia in hospitalized patients, and it is a helpful prognostic factor for mortality and other important clinical outcomes. Systematic review registration https://inplasy.com/inplasy-2022-9-0097/ , identifier INPLASY202290097.

medicine, general & internal
Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Zhixiang Chen,Lei Zha,Xiao Ma,Jing Xu,Dandan Huang,Wenlong Wu,Long Chen,Feng Yang,Weiling Liao,Wenhua Wang

DOI: https://doi.org/10.1007/s00408-022-00568-5

2022-09-16

Lung

Abstract:Low serum creatinine/cystatin C ratio (CCR) is associated with unfavorable characteristics in patients with chronic obstructive pulmonary disease (COPD); however, the relationship between CCR and in-hospital mortality of patients with acute exacerbation of COPD (AECOPD) is unexplored. Our objective was to assess the value of CCR for predicting in-hospital mortality of patients hospitalized with AECOPD.

respiratory system
Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study

Xuanna Zhao,Ruoxin Su,Rongwei Hu,Yujuan Chen,Xiaoyong Xu,Yalian Yuan,Jinhong Zhang,Wenchao Zhang,Yu Yang,Min Chen,Dongming Li,Bin Wu,Dan Huang,Dong Wu

DOI: https://doi.org/10.1186/s12877-023-03784-7

2023-02-11

Abstract:Background: Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle mass and function and has a negative impact on clinical outcomes associated with chronic obstructive pulmonary disease (COPD). Recently, the sarcopenia index (SI) was developed as a surrogate marker of sarcopenia based upon the serum creatinine to cystatin C ratio. We aimed to assess the value of SI for predicting clinically important outcomes among elderly patients with acute exacerbation of COPD (AECOPD). Methods: This cross-sectional study included elderly patients with AECOPD in China from 2017 to 2021. Clinical data were collected from medical records, and serum creatinine and cystatin C were measured. Outcomes included respiratory failure, heart failure, severe pneumonia, invasive mechanical ventilation, and mortality. Binary logistic regression was used to analyze the association between SI and clinical outcomes. Results: A total of 306 patients (260 men, 46 women, age range 60-88 years) were enrolled in this study. Among the total patients, the incidence of respiratory failure and severe pneumonia was negatively associated with SI values. After adjusting for potential confounding factors, binary logistic regression analyses showed that a higher SI was still independently associated with a lower risk of respiratory failure (odds ratio [OR]: 0.27, 95% confidence interval [CI]: 0.13-0.56, P < 0.05). In subgroup analysis, the incidence of respiratory failure was negatively associated with SI values in groups with both frequent exacerbation and non-frequent exacerbation. After adjustment for potential confounders, binary logistic regression analyses showed that a higher SI was also independently associated with a lower risk of respiratory failure in both groups (OR: 0.19, 95% CI: 0.06-0.64 and OR: 0.31, 95% CI: 0.11-0.85). However, there were no significant differences in the correlations between SI and the risk of heart failure, invasive mechanical ventilation, and mortality in all groups. Conclusion: The SI based on serum creatinine and cystatin C can predict respiratory failure in patients with AECOPD and either frequent or infrequent exacerbations. This indicator provides a convenient tool for clinicians when managing patients with AECOPD in daily clinical practice.
Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios As an Indicator of Severe Airflow Limitation in Older Adults

Jinxuan Li,Qi Sun,Hongguang Zhang,Bingjie Li,Chaoyu Zhang,Yixin Zhao,Jianbo Lu,Xu Ma

DOI: https://doi.org/10.3390/jcm12227116

IF: 3.9

2023-01-01

Journal of Clinical Medicine

Abstract:Background: This study aimed to investigate the association between the serum-creatinine-to-cystatin C-to-waist-circumference (CCR/WC) ratio with lung function and severe airflow limitation (SAL). Methods: The data were derived from the China Health and Retirement Longitudinal Study. Peak expiratory flow (PEF) was used as a measure of lung function parameter. Logistic and linear regression were utilized separately to evaluate the relationship between the CCR/WC ratio with PEF and SAL in baseline. Restricted cubic spline was used to explore potential non-linear associations between the CCR/WC ratio and SAL. Cox proportional-hazards models were used to assess the association between CCR/WC quartiles and the risk of new-onset SAL. Results: A total of 6105 participants were included. This study revealed a positive association between the CCR/WC ratio and lung function (PEF: β [partial coefficient]: 25.95, 95%CI: 12.72 to 39.18, p < 0.001; PEF/PEF prediction: β = 0.08, 95%CI: 0.05 to 0.12, p < 0.001) and an inverse association relationship with SAL (OR [odds ratio]: 0.64, 95% confidence interval [CI]: 0.47 to 0.85, p = 0.003). Subgroup analysis showed a significant association between the CCR/WC ratio and SAL in males (OR: 0.58, 95% CI: 0.37 to 0.90, p = 0.017) but not in females (p = 0.059). Cox regression analysis revealed a decreased risk of SAL in the quartiles (Q2–4) compared to the first quartile of the CCR/WC ratio (hazard ratios [HRs]: 0.49 to 0.73, all p < 0.05). Conclusions: This study highlights a positive association between the CCR/WC ratio and lung function, with a potential protective effect against SAL.
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease

Tatsuki Ichikawa,Hisamitsu Miyaaki,Satoshi Miuma,Yasuhide Motoyoshi,Mio Yamashima,Shinobu Yamamichi,Makiko Koike,Youichi Takahashi,Tetsurou Honda,Hiroyuki Yajima,Ryouhei Uehara,Naoyuki Hino,Ryousuke Hirata,Naota Taura,Kazuhiko Nakao

DOI: https://doi.org/10.3892/br.2020.1273

Abstract:Serum creatinine (Cr)-based glomerular filtration rate (CrGFR) is overestimated in liver disease. The present study evaluated whether the difference in CrGFR and cystatin C (CysC) GFR (dGFR) is significant in liver disease. The Cr-to-CysC ratio and sarcopenia index (SI) have been reported to correlate with muscle volume. An estimated total body muscle mass with Cr, CysC and calculated body muscle mass (CBMM) has also been reported to correlate with muscle mass. The applicability of dGFR, SI and CBMM for liver disease were evaluated. A total of 313 patients with liver damage were evaluated for Child-Pugh score, albumin-bilirubin (ALBI) score, model for end-stage liver disease, fibrosis-4, Cr, CysC, Cr-based estimated GFR (CreGFR), CysCGFR and grip strength. Of the 313 patients, 199 were evaluated using cross-sectional computed tomography (CT) of the third lumbar vertebra to determine the skeletal muscle (SM) mass. dGFR, CBMM and SI were compared to liver damage, muscle strength and muscle mass. In the 313 patients, dGFR was correlated with age, ALBI and grip strength; CBMM was correlated with body mass index (BMI) and grip strength; and SI was correlated with BMI and grip strength. In patients evaluated with CT, the correlation coefficients for CBMM and SI with SM were 0.804 and 0.293, respectively. Thus, CBMM and SI were associated with sarcopenia. The relationship between dGFR and ALBI does not differ with different grades of CrGFR-based chronic kidney disease (CKD). dGFR is a marker of liver damage and muscle strength regardless of CKD. CBMM and SI are markers for sarcopenia in liver disease.
Association of computed tomography-derived pectoralis muscle area and density with disease severity and respiratory symptoms in patients with chronic obstructive pulmonary disease: A case-control study

Can Li,Xinying Lian,Jingchun He,Xiao Gao,Xuehuan Liu,Cuiping Bao,Zuoxi Li,Weiwei Cui,Li Yu,Jun Liu

DOI: https://doi.org/10.1016/j.rmed.2024.107783

Abstract:Rationale and objectives: Computed tomography (CT) is commonly used and offers an additional viewpoint for evaluating extrapulmonary symptoms, disease severity, and muscle atrophy. This study assessed whether the pectoralis muscle area (PMA) and pectoralis muscle density (PMD) are lower in patients with chronic obstructive pulmonary disease (COPD) than in healthy controls and elucidated their relationships with these variables. Materials and methods: The participants were enrolled in the hospital outpatient clinic between October 2023 and May 2024. Information was obtained from questionnaires, lung function, and CT imaging findings. On full-inspiratory CT, the PMA and PMD were measured at the aortic arch level using predetermined attenuation ranges of -29 and 150 Hounsfield units. We observed lower PMA and PMD and evaluated their associations with lung function, respiratory symptoms, and CT imaging findings in patients with COPD. Results: Overall, 120 participants were enrolled at baseline (60 healthy controls and 60 patients with COPD). PMA and PMD were lower with progressive airflow limitation severity in those with COPD. The degree of emphysema and air trapping, as well as lung function, were correlated with PMA and PMD (P < 0.05), although not with the COPD Assessment Test or modified Medical Research Council scores (P > 0.05). Conclusion: Participants with COPD had smaller PMA and PMD. These measurements were correlated with the severity of airflow limitation, lung function, emphysema, and air trapping, suggesting that these features of the pectoralis muscle obtained from CT are helpful in assessments of patients with COPD.
Correlation Analysis of CT Quantitative Analysis and Changes of Chest Muscle in COPD Patients

zou dianjun,xu xiaowei,zhu xiaolong,yang fei,li chuangui,cui shujun,zhu yuexiang

DOI: https://doi.org/10.3969/j.issn.1674-1633.2017.12.024

2017-01-01

Abstract:Objective To evaluate the correlation between chest muscle area and chronic obstructive pulmonary disease(COPD) in patients with COPD, and to determine the correlation between the size of the chest muscle area and the acute exacerbation period and the body mass index of patients with COPD. Methods A total of 73 cases in ECLIPSE group were included in the study to evaluate the association between the pectoralis major muscle and fat weight measurement. For COPD genetic group, a total of 966 COPD subjects were included to analyze the correlation between the pectoralis major area and clinical characteristics. The area of chest muscle was evaluated by the radiologists in a double blind. Results In the ECLIPSE group, the R2 correlation between the pectoralis major muscle area and lean body weight was 0.76. COPD experimental group of pectoralis major area was lower than that of the control group, with statistical significance in COPD genome. The entire experimental group had higher forced expiratory volume(FEV1) and forced vital capacity(FVC). The FEV1/FVC ratio showed there was very little airway obstruction. After correction of the age, gender, height and smoking history, the FEV1 predictive value of correlation was significantly increased by 0.81%(95% CI 0.63-0.99, P<0.001) when the pectoralis major muscle area increased by 1 cm2. Correspondingly, the correlation of emphysema decreased by 0.63%(95%CI-0.7-0.51, P<0.001). CT quantitative analysis was significantly associated with SGRQ score, Sp O2 score, SGRQ level, 6 min walk distance, BODE index score, MMRC dyspnea score and disease exacerbation. Conclusion There is correlation between the CT measurement of the cross-sectional area of the large chest muscle and the severity of COPD. Besides, the measurement of the area of the chest muscle can predict the course and severity of acute exacerbation of COPD.
The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study

Xiangping Tu,Taiping Lin,Li Huang,Tianjiao Tang,Dongmei Xie,Langli Gao,Tingting Jiang,Jirong Yue

DOI: https://doi.org/10.1007/s41999-024-00948-5

2024-02-24

European Geriatric Medicine

Abstract:To compare the diagnostic accuracy of Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score for sarcopenia and investigate the predictive value of Cr/CysC concerning clinical outcomes in hospitalized older adults. Cr/CysC could effectively detect sarcopenia and predict poor outcomes in hospitalized older adults. A more precise sarcopenia screening may be offered by combining Cr/CysC with SARC-CalF. In our study, the Ishii score may be the most accurate clinical method for detecting sarcopenia. Cr/CysC could be used to screen for sarcopenia and predict poor outcomes in clinical settings. The utilization of the creatinine-to-cystatin C ratio (Cr/CysC) represents an innovative method for predicting sarcopenia. Our objectives encompassed the evaluation of sarcopenia diagnostic accuracy for Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score, as well as an exploration of the predictive value of Cr/CysC concerning clinical outcomes within hospitalized older individuals. We employed receiver operating characteristic (ROC) curves and calculated areas under the curves (AUCs) to assess the diagnostic accuracy. Furthermore, we applied univariate and multivariate Cox proportional-hazard models to calculate the hazard ratio (HR) and 95% confidence interval (CI) of risk factors affecting prognosis. Our study included 312 participants, comprising 167 men and 145 women, with an average age of 71 years. Among males, the AUCs for Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score were 0.717 [95% CI 0.642–0.784], 0.669 (95% CI 0.592–0.739), 0.845 (95% CI 0.781–0.896), 0.882 (95% CI 0.823–0.926), and 0.938 (95% CI 0.890–0.969), respectively. In females, the AUCs for Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score were 0.706 (95% CI 0.625–0.779), 0.631 (95% CI 0.547–0.710), 0.763 (95% CI 0.686–0.830), 0.789 (95% CI 0.714–0.853), and 0.898 (95% CI 0.837–0.942), respectively. After adjusting for age, sex, physical exercise, smoking, drinking, hypertension, coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), and cancer, sarcopenia identified by Cr/CysC (adjusted HR = 2.176, 95% CI 1.062–4.460, P = 0.034) was independently associated with poor overall survival in hospitalized older patients. Cr/CysC has satisfactory diagnostic accuracy for sarcopenia diagnosis and predictive value for poor outcomes in hospitalized older patients. The combination of Cr/CysC and SARC-CalF may provide a more accurate screening for sarcopenia and the Ishii score may be the most accurate clinical method for detecting sarcopenia.

geriatrics & gerontology,gerontology
Ultrasonic Elastography of the Rectus Femoris, a Potential Tool to Predict Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease

Mingming Deng,Xiaoming Zhou,Yanxia Li,Yan Yin,Chaonan Liang,Qin Zhang,Jingwen Lu,Mengchan Wang,Yu Wang,Yue Sun,Ruixia Li,Liming Yan,Qiuyue Wang,Gang Hou

DOI: https://doi.org/10.3389/fphys.2021.783421

IF: 4

2022-01-05

Frontiers in Physiology

Abstract:Purpose: Skeletal muscle dysfunction is common in patients with chronic obstructive pulmonary disease (COPD) and is associated with a poor prognosis. Abnormal muscle quantity of the lower limbs is a manifestation of skeletal muscle dysfunction in patients with COPD. Shear wave ultrasound elastography (SWE) is a novel and possible tool to evaluate qualitative muscle parameters. This study explores the feasibility of SWE to measure the stiffness of the rectus femoris and evaluates its value in predicting sarcopenia in patients with COPD. Methods: Ultrasound examination of the rectus femoris was performed to determine the mean elasticity index (SWE mean ), cross-sectional area (RF csa ), and thickness (RF thick ) using grayscale ultrasonography (US) and SWE in 53 patients with COPD and 23 age-matched non-COPD healthy controls. The serum levels of circulating biomarkers (GDF15, resistin, and TNF-α) were measured using ELISA. The definition of sarcopenia followed the guidelines from the Asian Working Group for Sarcopenia. Receiver operating characteristic (ROC) curve analysis of the SWE mean , RF thick , and RF csa was used to evaluate their predictive ability for sarcopenia. Results: The intraobserver and interobserver repeatability of SWE performance was excellent (all correlation coefficients > 0.95; p < 0.05). The SWE mean of the rectus femoris in patients with COPD (8.98 ± 3.12 kPa) was decreased compared with that in healthy controls (17.00 ± 5.14 kPa) and decreased with advanced global initiative for chronic obstructive lung disease (GOLD) stage. Furthermore, SWE mean was found to be independent of sex, height, and body mass, and a lower SWE mean in patients with COPD was positively associated with reduced pulmonary function, worse physical function, poor exercise tolerance, decreased muscle strength, and worse dyspnea index score. The correlation between physical function [five-repetition sit-to-stand test (5STST)], muscle function, and SWE mean was higher than those of RF thick and RF csa . In addition, SWE mean was negatively correlated with serum GDF15 levels ( r = −0.472, p < 0.001), serum resistin levels ( r = −0.291, p = 0.035), and serum TNF-α levels ( r = −0.433, p = 0.001). Finally, the predictive power of SWE mean [area under the curve (AUC): 0.863] in the diagnosis of sarcopenia was higher than that of RF thick (AUC: 0.802) and RF csa (AUC: 0.816). Conclusion: Compared with grayscale US, SWE was not affected by the patient’s height, weight, or BMI and better represented skeletal muscle function and physical function. Furthermore, SWE is a promising potential tool to predict sarcopenia in patients with COPD.

physiology
IDDF2020-ABS-0159 A New Diagnostic Index of Skeletal Muscle Mass for Predicting Short-Term Postoperative Complications in Crohn’s Disease

Xiaolong Ge,Linna Ye,Qian Cao,Wei Zhou

DOI: https://doi.org/10.1136/gutjnl-2020-iddf.101

2020-01-01

Abstract:Background Skeletal muscle depletion has been suggested to affect postoperative complications in surgical patients. The creatinine-to-cystatin C ratio (CCR) is demonstrated as a new marker of muscle mass. The present study investigated the role of CCR in predicting postoperative complications in Crohn’s disease (CD). Methods This cohort study included 344 CD patients undergoing bowel resection from January 2016 to June 2019 at the Inflammatory Bowel Disease Center, Sir Run Run Shaw Hospital. Univariate and multivariate analyses were performed to identify risk factors for postoperative complications in CD. Receiver operating characteristic (ROC) curves were developed to examine the cutoff value of predictors in postoperative complications. Results Among all the patients, 120 (34.9%) had postoperative complications and 224 (65.1%) recovered uneventfully. Preoperative albumin, C-reactive protein, white blood cell, creatinine, cystatin C, CCR, operative time, surgical history, laparoscopy, estimated blood loss, azathioprine and corticosteroids usage, and enteral nutrition were demonstrated to predict postoperative complications in CD (all p value < 0.05). Additionally, higher white blood cell (p=0.008), lower creatinine (p<0.001), higher cystatin C (p=0.002), lower CCR (p=0.002), and enteral nutrition (p=0.001) were identified to be independent risk factors in CD patients. CCR was identified to be with the highest area under the curve compared with other predictors, and the cutoff value was 7.804. Patients with a CCR < 7.804 experienced more postoperative complications, including surgical site infections (p<0.001). Conclusions CCR was a simple and useful predictor as evaluating skeletal muscle mass to identify patients with a high incidence of postoperative complications in CD.

Conditional Value-at-Risk: Structure and Complexity of Equilibria

Infinitely Many Heteroclinic Orbits of a Complex Lorenz System

Femtosecond laser-assisted lock-and-key shaped penetrating keratoplasty

Creatinine-to-cystatin C Ratio As a Marker of Skeletal Muscle Mass for Predicting Postoperative Complications in Patients Undergoing Gastric Cancer Surgery.

Cardiovascular changes during transport of critically ill and postoperative patients

Quantitative Computed Tomography Assessment of Pectoralis and Erector Spinae Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease Referred for Lung Volume Reduction

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

Letter: Ultrasound in diagnosis of empyema.

The creatinine-to-cystatin C ratio (a surrogate marker of muscle mass) as a predictor of lung function decline in older adults: A nationwide longitudinal study in China

Ageing, remembering, and executive function

Serum cystatin C and indices of lung function in elderly Chinese men with chronic obstructive pulmonary disease

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis

Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study

Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios As an Indicator of Severe Airflow Limitation in Older Adults

Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease

Association of computed tomography-derived pectoralis muscle area and density with disease severity and respiratory symptoms in patients with chronic obstructive pulmonary disease: A case-control study

Correlation Analysis of CT Quantitative Analysis and Changes of Chest Muscle in COPD Patients

The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study

Ultrasonic Elastography of the Rectus Femoris, a Potential Tool to Predict Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease

IDDF2020-ABS-0159 A New Diagnostic Index of Skeletal Muscle Mass for Predicting Short-Term Postoperative Complications in Crohn’s Disease